What is Haemonetics's PP&E sale proceeds?

Haemonetics (HAE) reported PP&E sale proceeds of $526K in Q1 2026.

How has Haemonetics's PP&E sale proceeds changed year-over-year?

Haemonetics's PP&E sale proceeds decreased by 78.5% year-over-year, from $2.45M to $526K.

What is the long-term trend for Haemonetics's PP&E sale proceeds?

Over 3 years (2022 to 2026), Haemonetics's PP&E sale proceeds has grown at a -12.1% compound annual growth rate (CAGR), from $2.02M to $1.38M.

What does PP&E sale proceeds mean?

Cash received from selling property, plant, and equipment no longer needed for operations.

Haemonetics HAE PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

ICU MedicalICUI

$1K-97.6%

DanaherDHR

$0-100%

Bio-Rad LaboratoriesBIO

$100K—

ITG

Integer HoldingsITGR

$55K+1,000%

RepligenRGEN

$0-100%

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's PP&E sale proceeds?: Haemonetics (HAE) reported PP&E sale proceeds of $526K in Q1 2026.
How has Haemonetics's PP&E sale proceeds changed year-over-year?: Haemonetics's PP&E sale proceeds decreased by 78.5% year-over-year, from $2.45M to $526K.
What is the long-term trend for Haemonetics's PP&E sale proceeds?: Over 3 years (2022 to 2026), Haemonetics's PP&E sale proceeds has grown at a -12.1% compound annual growth rate (CAGR), from $2.02M to $1.38M.
What does PP&E sale proceeds mean?: Cash received from selling property, plant, and equipment no longer needed for operations.